Evidence map›Paper›PMID 23451035›Full record

ArticlePloS one2013

Key role of group v secreted phospholipase A2 in Th2 cytokine and dendritic cell-driven airway hyperresponsiveness and remodeling.

William R Henderson, Xin Ye, Ying Lai, Zhanglin Ni, James G Bollinger, Ying-Tzang Tien, Emil Y Chi, Michael H Gelb

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Regulatory Roles of Phospholipase AFrontiers in immunology · 2022
    Review
  3. Harmful and protective roles of group V phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  4. Article
  5. Lipoquality control by phospholipase AProceedings of the Japan Academy. Series B, Physical and biological sciences · 2017
    Review
  6. Identification of Epithelial Phospholipase AAmerican journal of respiratory cell and molecular biology · 2016
    Article
  7. Article
  8. Epigenetic control of group V phospholipase A2 expression in human malignant cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  9. The Roles of the Secreted Phospholipase AAdvances in immunology · 2016
    Review
  10. Review
  11. A new era of secreted phospholipase A₂.Journal of lipid research · 2015
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

William R HendersonCenter for Allergy and Inflammation, UW Medicine at South Lake Union, Department of Medicine, University of Washington, Seattle, Washington, United States of America. wrhchem@u.washington.edu
Xin Ye
Ying Lai
Zhanglin Ni
James G Bollinger
Ying-Tzang Tien
Emil Y Chi
Michael H Gelb
University of Washington · USCenter for Urban Waters · US

Funding

Biochemical Studies of 14-kDa Phospholipases A2R37HL036235 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 2007 to 2016
$4.1M
5-LIPOXYGENASE PRODUCTS IN ASTHMATIC IMMUNE RESPONSER01AI042989 · NIAID · UNIVERSITY OF WASHINGTON · PI HENDERSON, WILLIAM REED · 1998 to 2008
$2.4M
Chemogenomics to Identify New Molecular Targets in PFR01HL073722 · NHLBI · UNIVERSITY OF WASHINGTON · PI HENDERSON, WILLIAM REED · 2003 to 2006
$2.4M
NHLBI NIH HHS HL 73722NHLBI NIH HHS R01 HL073722NHLBI NIH HHS R37 HL036235NHLBI NIH HHS R37 HL36235NIAID NIH HHS R01 AI042989NIAID NIH HHS R01 AI 42989
6 · The paper itself

Abstract

backgroundPrevious work has shown that disruption of the gene for group X secreted phospholipase A2 (sPLA2-X) markedly diminishes airway hyperresponsiveness and remodeling in a mouse asthma model. With the large number of additional sPLA2s in the mammalian genome, the involvement of other sPLA2s in the asthma model is possible - in particular, the group V sPLA2 (sPLA2-V) that like sPLA2-X is highly active at hydrolyzing membranes of mammalian cells. METHODOLOGY AND PRINCIPAL

findingsThe allergen-driven asthma phenotype was significantly reduced in sPLA2-V-deficient mice but to a lesser extent than observed previously in sPLA2-X-deficient mice. The most striking difference observed between the sPLA2-V and sPLA2-X knockouts was the significant impairment of the primary immune response to the allergen ovalbumin (OVA) in the sPLA2-V(-/-) mice. The impairment in eicosanoid generation and dendritic cell activation in sPLA2-V(-/-) mice diminishes Th2 cytokine responses in the airways.

conclusionsThis paper illustrates the diverse roles of sPLA2s in the immunopathogenesis of the asthma phenotype and directs attention to developing specific inhibitors of sPLA2-V as a potential new therapy to treat asthma and other allergic disorders.

Indexed as

AnimalsAsthmaCD4-Positive T-LymphocytesDisease Models, AnimalGroup V Phospholipases A2Group X Phospholipases A2ImmunohistochemistryMiceMice, KnockoutOvalbuminPolymerase Chain ReactionTh2 CellsGroup V Phospholipases A2Group X Phospholipases A2Ovalbumin

Identifiers

PMID23451035
PMCPMC3581544
OpenAlexW2164696627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.